[HTML][HTML] Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women
A Zimmermann, D Bernuit, C Gerlinger, M Schaefers… - BMC women's …, 2012 - Springer
Background In 2009 the Uterine Bleeding and Pain Women's Research Study (UBP-WRS)
was conducted interviewing 21,479 women across 8 countries in order to gain patient-based …
was conducted interviewing 21,479 women across 8 countries in order to gain patient-based …
Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study
T Strowitzki, T Faustmann, C Gerlinger… - European Journal of …, 2010 - Elsevier
OBJECTIVE: To investigate the efficacy and safety of oral dienogest 2mg compared with
placebo in the treatment of endometriosis-associated pelvic pain (EAPP). STUDY DESIGN: This …
placebo in the treatment of endometriosis-associated pelvic pain (EAPP). STUDY DESIGN: This …
[HTML][HTML] Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
…, D Hornung, C Seitz, T Faustmann, C Gerlinger… - Archives of gynecology …, 2012 - Springer
Purpose To investigate the efficacy and safety of dienogest as a long-term treatment in
endometriosis, with follow-up after treatment discontinuation. The study included women with …
endometriosis, with follow-up after treatment discontinuation. The study included women with …
The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
…, CW van Haselen, EJ van Zuuren, C Gerlinger… - Cutis, 2002 - europepmc.org
A new oral contraceptive has been developed that contains a unique progestogen,
drospirenone (DRSP), and that has both antiandrogenic and antimineralocorticoid activity. Our …
drospirenone (DRSP), and that has both antiandrogenic and antimineralocorticoid activity. Our …
A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis
G Köhler, TA Faustmann, C Gerlinger, C Seitz… - International Journal of …, 2010 - Elsevier
OBJECTIVES: To compare the efficacy and safety of dienogest at doses of 1, 2, and 4mg/day
orally in the treatment of endometriosis. METHODS: An open-label, randomized, multicenter…
orally in the treatment of endometriosis. METHODS: An open-label, randomized, multicenter…
Characterization of the “frequent exacerbator phenotype” in bronchiectasis
…, TC Fardon, D Obradovic, C Gerlinger… - American journal of …, 2018 - atsjournals.org
Rationale: Exacerbations are key events in the natural history of bronchiectasis, but clinical
predictors and outcomes of patients with frequently exacerbating disease are not well …
predictors and outcomes of patients with frequently exacerbating disease are not well …
[HTML][HTML] Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo …
C Gerlinger, U Schumacher, T Faustmann… - Health and quality of life …, 2010 - Springer
Background When comparing active treatments, a non-inferiority (or one-sided equivalence)
study design is often used. This design requires the definition of a non-inferiority margin, the …
study design is often used. This design requires the definition of a non-inferiority margin, the …
Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program
T Strowitzki, T Faustmann, C Gerlinger… - … journal of women's …, 2015 - Taylor & Francis
Background In four randomized, controlled, European trials, dienogest 2 mg once daily
demonstrated significant efficacy for lesion reduction and reduction in pain intensity in …
demonstrated significant efficacy for lesion reduction and reduction in pain intensity in …
[HTML][HTML] Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results
C Gerlinger, L Bamber, F Leverkus, C Schwenke… - BMC research …, 2019 - Springer
Objective To compare the country-specific value sets of the EQ-5D-5L utility index and to
evaluate the impact on the interpretation of clinical study results. Six country value sets from …
evaluate the impact on the interpretation of clinical study results. Six country value sets from …
[HTML][HTML] Responsible data sharing in international health research: a systematic review of principles and norms
S Kalkman, M Mostert, C Gerlinger, JJM van Delden… - BMC medical …, 2019 - Springer
Background Large-scale linkage of international clinical datasets could lead to unique insights
into disease aetiology and facilitate treatment evaluation and drug development. Hereto, …
into disease aetiology and facilitate treatment evaluation and drug development. Hereto, …
